Sponsored by:

TCT: Transcatheter Cardiovascular Therapeutics

November 7-11, 2011 - San Francisco, CA

TCT 2011
Note that some of these links take you to a site outside of CardioSource.
CardioSource does not assume responsibility for content of external sites.

Wednesday November 16 2011

  • Wrap-up of TCT 2011

    Dr. Peter Block discusses the highlights of science presented at TCT 2011.

Tuesday November 15 2011

  • Genetic Tests, Stent Thrombosis Highlight Meeting

    SAN FRANCISCO — With more than 22 late-breaking trials, 650 abstracts, 100 live cases, and more than 3,000 presentations, the 12,000 people in attendance at this year's Transcatheter Cardiovascular Therapeutics meeting had a lot to choose from.

  • Longitudinal Stent Compression Needs More Study

    SAN FRANCISCO — Longitudinal stent compression is rare and most often used in complex cases by operators experienced in the technique, but more research is needed to assess its potential effects, according to researchers here.

Monday November 14 2011

  • Uptake of DAPT After Stenting Unclear

    SAN FRANCISCO — Research continues to assess the optimal duration and potential for customization of dual antiplatelet therapy for stented patients, but it's unclear whether results of recent studies are being put into practice, Roxana Mehran, MD, explains in this exclusive InFocus report.

  • Newest Stents Cut Polymer Threat

    SAN FRANCISCO — A pair of experimental third-generation stents with minimized amounts of polymer coating are at least noninferior to previous stents in early trials, researchers reported here.

Saturday November 12 2011

  • Combo Stent Comparable to Taxus

    SAN FRANCISCO — A combination stent that incorporates an antiproliferative drug and an agent that promotes healing works as well as a paclitaxel-eluting stent, researchers reported here.

  • New Pressure Index Is FFR Minus Adenosine

    SAN FRANCISCO — A new pressure-based index to measure the severity of coronary lesion stenosis without adenosine compared favorably to fractional flow reserve (FFR) with adenosine, researchers found.

Friday November 11 2011

  • PROFI

    A Prospective, Randomized Trial of Proximal Balloon Occlusion vs. Distal Filter Embolic Protection in Patients Undergoing Carotid Stenting

  • COBRA

    A Prospective, Randomized Trial of Cryoplasty vs. Conventional Balloon Post-dilatation of Nitinol Stents in the Superficial Femoral Artery of Patients with Diabetes Mellitus

  • TWENTE

    A Prospective, Randomized Trial of Zotarolimus-Eluting Stents and Everolimus-Eluting Stents in an Unselected Patients with Coronary Artery Disease

  • Longitudinal Stent Compression Rare but Not Deadly

    SAN FRANCISCO — The publication of a few case reports has brought longitudinal stent compression into the spotlight, and interventional cardiologists need to be aware of the issue, says Ajay Kirtane, MD, in this exclusive InFocus video report.

  • Access Site Drives TAVI Costs, Quality

    SAN FRANCISCO — Compared with surgery, quality of life was significantly improved for patients undergoing transcatheter aortic valve implantation (TAVI) from a transfemoral approach, but no such effect was seen in those undergoing TAVI from a transapical approach, researchers here reported.

Thursday November 10 2011

Wednesday November 9 2011

Tuesday November 8 2011

  • LEADERS

    Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

  • Team Work Replaces Turf Wars in Heart Disease

    SAN FRANCISCO — Cooperation is rapidly replacing competition in the cardiovascular world as both surgeons and interventionalists are signing on to the "heart team" for treatment of patients with stable coronary disease as interventional cardiologist J. Jeffrey Marshall, MD, explains in this exclusive InFocus video report on the American College of Cardiology/American Heart Association revascularization guidelines.

  • Access Location Doesn't Change Radiation Exposure

    SAN FRANCISCO — Transradial access for angiography or stenting does not increase patients' radiation exposure compared with femoral access, researchers said here.

  • Risk Model Predicts PCI Outcome

    SAN FRANCISCO — A risk assessment score that uses age, creatinine level, and ejection fraction (ACEF) was a good predictor of death in patients undergoing PCI in routine clinical practice, researchers found.

Monday November 7 2011

  • Full Plate of Late-Breakers on Tap in San Francisco

    SAN FRANCISCO — At this year's Transcatheter Cardiovascular Therapeutics meeting, there are some 20 late-breaking trial presentations with more than a few with the potential to impact clinical practice if the results are positive.

Advertisement
Advertisement